IRONWOOD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IRONWOOD
IRONWOOD has two approved drugs.
There are nine US patents protecting IRONWOOD drugs.
There are one hundred and eighty-two patent family members on IRONWOOD drugs in forty-two countries and thirty-five supplementary protection certificates in eighteen countries.
Summary for IRONWOOD
| International Patents: | 182 |
| US Patents: | 9 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for IRONWOOD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 9,216,179 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-002 | Aug 18, 2017 | DISCN | Yes | No | 8,003,681 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
| Ironwood Pharms Inc | ZURAMPIC | lesinurad | TABLET;ORAL | 207988-001 | Dec 22, 2015 | DISCN | Yes | No | 8,084,483 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Ironwood Pharms Inc | DUZALLO | allopurinol; lesinurad | TABLET;ORAL | 209203-001 | Aug 18, 2017 | DISCN | Yes | No | 8,357,713 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IRONWOOD Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2670700 | ⤷ Try for Free |
| Mexico | 2011002449 | ⤷ Try for Free |
| Spain | 2513390 | ⤷ Try for Free |
| Hungary | E031766 | ⤷ Try for Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for IRONWOOD Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2217577 | CR 2019 00003 | Denmark | ⤷ Try for Free | PRODUCT NAME: ALLOPURINOL AND LESINURAD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/18/1300 20180827 |
| 2217577 | 300970 | Netherlands | ⤷ Try for Free | PRODUCT NAME: DUZALLO - ALLOPURINOL/LESINURAD OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/18/1300 20180827 |
| 2217577 | 122019000008 | Germany | ⤷ Try for Free | PRODUCT NAME: DUZALLO - ALLOPURINOL / LESINURAD ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ ODER VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/1/18/1300 20180823 |
| 2135608 | 16C0031 | France | ⤷ Try for Free | PRODUCT NAME: LESINURAD; REGISTRATION NO/DATE: EU/1/15/1080 20160222 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
